2. Others Neuronal Signaling Membrane Transporter/Ion Channel Metabolic Enzyme/Protease TGF-beta/Smad Epigenetics
  3. Isotope-Labeled Compounds GlyT Endogenous Metabolite PKC
  4. 1064364-21-1

1064364-21-1

4’-C-Methyl-4-deoxyuridine Chemical Structure

1064364-21-1

Chemical Structure

  • 4’-C-Methyl-4-deoxyuridine
  • CAS No: 1064364-21-1
    Formula: C10H14N2O5
    Molecular Weight: 242.23
  • IUPAC Name: 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-5-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one
  • InChIKey: MKIZZXNZJLIWIA-IBCQBUCCSA-N
  • SMILES: C[C@@]1(CO)[C@@H](O)[C@@H](O)[C@H](N2C=CC=NC2=O)O1

Biological Activity: 4’-C-Methyl-4-deoxyuridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Cat. No. Product Name Purity Description
HY-152548 4’-C-Methyl-4-deoxyuridine 4’-C-Methyl-4-deoxyuridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.

References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [Content Brief]

Keywords:

4’-C-Methyl-4-deoxyuridine